Kabiven Peripheral

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Kabiven Peripheral, is a parenteral nutrition presented as a solution for injection for intravenous use. It provides essential amino acids for patients unable to receive adequate enteral nutrition.

GNH USA supplies Kabiven Peripheral as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Kabiven Peripheral is used in parenteral nutrition to support patients with insufficient oral or enteral intake.

- Inadequate oral or enteral intake: provides a complete amino acid profile to meet protein requirements. - Post‑operative nutritional support: helps maintain nitrogen balance during recovery. - Critical care patients requiring amino acid supplementation: supports metabolic needs in intensive care settings.

Kabiven Peripheral may be associated with infusion‑related adverse reactions and metabolic disturbances.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: changes in potassium, sodium, or calcium concentrations. - Phlebitis: inflammation at the infusion site. - Metabolic acidosis: decreased blood pH in susceptible patients.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate intervention. - Hyperosmolarity-related complications: renal dysfunction or cerebral edema. - Sepsis: infection related to catheter or contaminated solution. - Thrombophlebitis: clot formation with vein inflammation.

When using Kabiven Peripheral, clinicians should observe several safety considerations.

- Patient assessment: evaluate renal and hepatic function before initiation. - Monitoring: check blood glucose, electrolytes, and acid‑base status regularly. - Compatibility: verify compatibility with other IV drugs and avoid mixing in same line unless proven safe. - Volume overload: assess fluid status to prevent circulatory overload. - Infusion rate: administer according to prescribed rate to reduce risk of metabolic complications. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven Peripheral can interact with certain medications and solutions administered intravenously.

Major Interactions (Avoid): - Insulin therapy: concurrent high‑dose insulin may cause severe hypoglycemia. - Loop diuretics: may exacerbate electrolyte disturbances, especially potassium loss. - Calcium‑containing solutions: can precipitate when mixed with certain amino acid solutions.

Moderate Interactions (Monitor Closely): - Anticoagulants: amino acids may affect coagulation parameters; monitor INR or aPTT. - Beta‑adrenergic agonists: may influence potassium shifts; watch serum potassium. - Other parenteral nutrition components: ensure total nutrient load does not exceed recommended limits.